VYNE - VYNE Therapeutics (VYNE) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript

VYNE Therapeutics (VYNE) Q3 2020 Earnings Conference Call November 5, 2020 08:30 AM ET Company Participants Michael Wood - LifeSci Advisors David Domzalski - Chief Executive Officer Matthew Wiley - Chief Commercial Officer Andrew Saik - Chief Financial Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald David Amsellem - Piper Sandler & Co. Ken Cacciatore - Cowen and Company Patrick Dolezal - LifeSci Capital Presentation Operator Good day, and welcome to the VYNE Therapeutics Third Quarter 2020 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Michael Wood, LifeSci Advisors. Please go ahead, sir. Michael Wood Thank you. Good morning, everyone and thank you for joining us this morning. Before we begin with formal remarks, let me remind you that some of the information in the press release that was issued by the Company this morning and on

For further details see:

VYNE Therapeutics (VYNE) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript